Striatal Dopaminergic Functioning in Patients with Sporadic and Hereditary Spastic Paraplegias with Parkinsonism.
10.3346/jkms.2013.28.11.1661
- Author:
Ji Seon KIM
1
;
Jong Min KIM
;
Yu Kyeong KIM
;
Sang Eun KIM
;
Ji Young YUN
;
Beom S JEON
Author Information
1. Department of Neurology, College of Medicine, Chungbuk National University Hospital, Cheongju, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Spastic Paraplegia, Hereditary;
Parkinsonian Disorders;
Dopamine Transporter Image
- MeSH:
Adult;
Aged;
Brain/*radionuclide imaging;
Dopamine Plasma Membrane Transport Proteins/metabolism;
Female;
Humans;
Male;
Middle Aged;
Organotechnetium Compounds/diagnostic use;
Paraplegia/diagnosis/genetics/*radionuclide imaging;
Parkinsonian Disorders/complications/genetics/*radionuclide imaging;
Pyramidal Tracts;
Radiopharmaceuticals/diagnostic use;
Spastic Paraplegia, Hereditary/diagnosis/genetics/*radionuclide imaging;
Tomography, Emission-Computed, Single-Photon
- From:Journal of Korean Medical Science
2013;28(11):1661-1666
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sporadic spastic paraplegia (SSP) and hereditary spastic paraplegia (HSP) belong to a clinical and genetically heterogeneous group of disorders characterized by progressive spasticity and weakness in the lower extremities. The symptoms are associated with pyramidal tract dysfunction and degeneration of the corticospinal tracts. Parkinsonism is uncommon in SSP/HSP patients. However, both disorders are associated with damage to the nigrostriatal dopaminergic system. In the present study, the clinical features of patients with SSP/HSP were investigated, and nigrostriatal dopaminergic binding potential was assessed using dopamine transporter (DAT) single-photon emission computer tomography (SPECT). Nine patients with spastic paraplegia participated in the present study. The subjects underwent DAT SPECT using the agent [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato (3-)-N2,N20,S2,S20]oxo-[IR-(exo-exo)])-[99mTc]technetium ([99mTc]TRODAT-1). The [99mTc]TRODAT-1 SPECT images of five patients appeared normal, whereas the images of four patients revealed reduced striatal ligand uptake. Among the four patients with reduced uptake, two had parkinsonism, and one exhibited periodic limb movements and restless leg syndrome. Our DAT SPECT imaging study shows that reduced DAT density may be observed in patients with parkinsonism. The results of the present study offer an explanation for the spectrum of spastic paraplegia symptoms and the progression of the disorder.
